Guidelines and adenosine dosing in supraventricular tachycardia.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 16243875.
- Also identified by PMC identifier 1720194.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This retrospective review of present practice of administration of adenosine by paediatricians shows that current guidelines recommend starting doses that are effective in only 9% of infants and children.
Medical subject headings
- Adenosine
- Anti-Arrhythmia Agents
- Practice Guidelines as Topic
- Tachycardia, Supraventricular